Health Archive » June, 2011

Health - June, 2011

228 articles

• 3rd Circ. Revives United Health Kickback Claim
• Medicare Will Cover Avastin Despite FDA Ruling
• Elan, Abbott Drop Teva Patent Suit Over Tricor
• ViiV Goes After Lupin Over HIV Drug ANDA
• Spotlight On Corporate Governance Rules For Insurers
• Same-Sex Marriage And NY Employee Benefits
• Merck, Sandoz Resolve Patent Suit Over Cancidas
• Impax Settles With Daiichi, Genzyme Over Generic Welchol
• Signalife, Investors Seek Approval For $4M Settlement
• Ex-Bio-Med Execs Can't Escape Convictions: 11th Circ.
• 3rd Circ. OKs State Liens On Medicaid Patient Awards
• HHS Subpoenas HealthSouth Over Medicare Fraud
• Somaxon Sues Mylan Again Over Generic Silenor
• FDA Panel Rules Avastin Unsafe For Breast Cancer Use
• 6th Circ. Backs Health Care Reform's Individual Mandate
• A Practical Guide To Discovery Conference Preparation
• EU, South Korea FTA To Address Nontariff Barriers
• Wilson Sonsini Snags Pharma Patent Pro From Foley
• Getting Specific About FCPA Compliance
• Doctors Blast Rosy Research For Medtronic Bone Device
• Judge Agrees With Watson's Take On Lidoderm Patent
• Roche Files 3 Patent Suits Over Generic Xeloda
• Pfizer Fights Aurobindo's Bid To Sell Generic Lipitor
• Barnes & Thornburg Adds 7 Akin Gump Attorneys In LA
• Medtronic Sues Edwards Over Heart Valve Patents
• Icahn Sues Forest Labs Over CEO Defense
• Quarles & Brady Adds Employee Benefits Atty In Wis.
• Experian To Buy Medical Billing Co. For $185M
• Judge Tosses FTC Suit Challenging Hospital Merger
• Mylan Takes $76M Antitrust Verdict To High Court
• UnitedHealth Seeks 2nd Remand Of GSK Paxil Action
• APP Takes Patent Contract Ruling To High Court
• New Charges Coming In Hospital Bribery Case, Feds Say
• AstraZeneca Sues Watson Over Generic Pulmicort
• Q&A With Much Shelist's Edward Shapiro
• Questions Remain On Class Certification Relitigation
• Zyprexa Payors' Off-Label Suit Denied By High Court
• GE Settles In $30M Radioactive Cleanup Suit
• Prandin Use Code Case Taken Up By High Court
• Atty Can't Represent AWP Classes, 1st Circ. Rules
• FDA Strengthens Warnings On Amgen, J&J Anemia Drugs
• W.Va. Supreme Court Revives Mylan Forum Challenge
• St. Jude Wins Injunction, Verdict Trimmed By $1.3B
• LeClairRyan Adds Roetzel White Collar Atty In DC
• 2nd Circ. Nixes $1.3B Asthma Drug Suit V. AstraZeneca
• How To Make It Rain By Marketing Individual Lawyers
• Mylan Crohn's Drug Doesn't Infringe AstraZeneca IP: Judge
• Novelos Shakes Class Action Over Cancer Drug Statements
• UnitedHealth Wins Access To GSK Litigation Info
• Novo Hit With Overtime, Break Action From Sales Rep
• Ceridian Sues Zeitgeist For $3.5M Over Guard Contract
• ConvaTec Dodges Hollister Incontinence Device IP Suit
• Teva Targets Apotex Over Generic Parkinson's Drug
• GSK To Pay States, DC $41M Over Drugmaking Lapses
• UnitedHealth To Pay $1M For Antitrust Pact Breach
• Modifying HIPAA Disclosure Accounting Provisions
• High Court Ruling May Hobble Suits Against Generics
• Smith & Nephew Wins $85M IP Verdict Against Arthrex
• Covidien Sales Rep OT Suit Should Be Certified: Judge
• Hospira Sued Over Infusion Patent, Sale Contract
• Feds Seek 30 Years For Doctor In $23M Medicare Fraud
• Mylan Resolves Shire Suit Over Generic Fosrenol
• Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
• Breast Implants Aren't Forever, FDA Warns
• Understanding The Advice-Of-Counsel Defense
• Judge OKs Replacement Of Dead Class Rep In Paxil Suit
• Sens. Order Medtronic To Turn Over Infuse Records
• Skadden Reps Dentsply In $1.8B AstraZeneca Unit Buy
• Transgender Court Clerk Sues Ore. For Coverage Denial
• House To Debate Diversion Of USPTO Fees
• UnitedHealth Sues DOD Over $24B Healthcare Contract
• Claims Cut From Ex-Eisai Worker's Whistleblower Suit
• FDA Wants Relaxed Sterility Test Rules For Bio Products
• Anthem Blue Cross Settles Policy Closure Action
• The FTC's War On 'Pay-For-Delay' Agreements
• Astellas Hits Sagent, Strides With Adenoscan IP Suit
• Sanofi Takes Sun To Court Over Generic Eloxatin
• Huron, Empire Renew Bid To Toss St. Vincent FCA Suit
• Depomed Fights Generic Threat To Glumetza
• Fallon Clinic Joins Atrius After Deal With Mass. AG
• FDA Implements 9 Graphic Cigarette Warning Labels
• Cancer Patients Win $3M In Supplemental Coverage Suit
• Wyeth Settles Patent Suit Over Generic Effexor
• Kaneka Sues Over Q10 Supplement Patent In ITC
• Owner Of Ill. Weight Loss Clinics Charged With Fraud
• Fed. Circ. Tosses $5M Award Over Knee Surgery Patent
• Akin Gump Adds 2 Litigators To Health Industry Practice
• USPTO Widens Patent Prosecution Highway
• High Court Declines To Weigh In On Patent Definiteness
• Supreme Court To Weigh Patentability Again In Mayo Case
• GSK Sues Roxane, Watson Over Generic Avodart
• J&J Wins 1st Trial Victory In Levaquin MDL
• High Court Won't Review $58M Award In Wyeth Drug Suit
• Fed. Circ. Stops Launch Of Watson's Generic Seasonique
• How They Won It: Morgan Lewis Snags $577M Verdict For Asahi
• J&J Unit Recalls 40,000 Bottles Of Risperidone
• FDA Calls Back Boston Scientific Stents, Catheters
• HHS Wrongly Denied Hospital Reimbursements: DC Circ.
• Addus Homecare, Investors Reach $3M Deal Over IPO
• Technological Tying And 'Predatory' Innovation
• The Ultimate 'Shareholder'
• AstraZeneca Drops Suit After Teva Nixes Generic Faslodex
• Judge Won't Block Watson's Generic Seasonique
• How They Won It: Steptoe Gets Rare Acquittal For GSK Atty
• Somaxon Sues Zydus Over Generic Silenor
• GSK's Rotavirus Vaccine Tied To Bowel Disorder
• Q&A With Locke Lord's Graham Hill
• AGA Hits Occlutech With IP Suits In Germany, UK
• Inside Smith V. Bayer
• NH Senate Can't Make AG Join Health Reform Suit: Court
• NY Court Refuses To Step Between Prosecutors, Amgen
• FDA Says Chantix Raises Risk Of Heart Attacks
• High Court Greenlights W.Va. Class Bid In Baycol Fight
• GAO Upholds $24B Humana Military Care Contract
• Apotex Can't Dodge Schering Suit Over Nasonex IP
• 8th Circ. Weighs Women's Right To Pursue Wyeth Claims
• Novartis, Roxane Settle Famvir Dispute
• GSK Shakes Humana Suit Over Avandia Injury Costs
• FDA Widens Recall Of Boston Scientific Catheters
• Exec Says US Can't Prove Intent In Bone Cement Case
• AmeriHealth Settles Eating Disorder Coverage Suit
• 3rd Circ. Affirms Dismissal Of Amgen Tying Suit
• FDA Warns Matrixx Over Zicam Marketing
• 9th Circ. Refuses To Rehear Pfizer-Wyeth Merger Suit
• Family Seeks $5M From Attys Who Won Suit With Bribes
• Novartis, Sun Settle IP Suit Over Generic Focalin
• Does Your Company Need An IP Protection Audit?
• FTC Seeks More Details On Teva's $6.8B Cephalon Buy
• Alcon Sues Watson To Block Pataday Generic
• Wis. Drug Cos. Face Temporary Shutdown After Raid
• DOJ Subpoenas Gilead Over HIV Drugs
• Humira Patient Sues Abbott Over Fungal Infection
• Extra Damages Possible In $22M Stent Suit: Fed. Circ.
• 3rd Circ. Lets HHS Off Hook For Pa. Disability Costs
• WL Gore Slaps Bard With Suit Over Stent Patent
• Davis Polk Reps Aetna In $290M Genworth Buy
• Ex-Pfizer Reps Seek Classes For NY, Calif., Ill.
• Germany Suspends Takeda Diabetes Drug Actos
• Pharma Holdings Defendants Get 10 Days To Yield Docs
• Novo Settles Drug Marketing Claims For $26.7M
• FDA Says Prostate Drugs Can Cause Cancer
• Pfizer Sanctions Affirmed In Neurontin Antitrust MDL
• Whistleblower Protections Restored: Sylvester V. Parexel
• Q&A With Bose McKinney's Mary Feldhake
• Negotiated Rate Differential Meets Collateral Source Rule
• One Court's Cynical View Of The Legislative Process
• Warner Chilcott Sues Mylan Over Loestrin ANDA
• Jury Finds Against Baxter In Chinese Heparin Suit
• Prosthetics Maker Wins Stay In Gel Liner IP Suit
• Fed. Circ. Upholds Hako-Med's Loss In Patent Suit
• Zocor Dangerous In High Doses, FDA Warns
• FDA Takes First Step Toward Regulating Nanotechnology
• Roche, Genentech Sued Over Encryption Patent
• EU Court Adviser Sides With Merck In Patent Term Fight
• 2nd Circ. Affirms $11M Hit Against Taro Insider Traders
• Cancer Patients Triumph In Supplemental Coverage Action
• UCB Agrees To Pay $34M Over Epilepsy Drug Labeling
• Insurer Can't Shake $2.5M Payout In Sex Abuse Case
• Lilly Sues Hetero To Block Generic Strattera
• Essentials For Success In Arbitration
• Schering-Plough Denied Injunction In Sunscreen Suit
• Medical Food Makers Settle False Advertising Suit
• 11th Circ. Weighs Health Law's Individual Mandate
• Lilly Wins TRO Battle In Byetta Marketing Case
• Mass. Hospitals Beat Worker Wage-And-Hour Action
• Pfizer Unit Yanks Poultry Drug After FDA Arsenic Study
• 8th Circ. Again Upholds Catheter Maker's Antitrust Win
• Lawyer Dad Settles SEC Insider Trading Suit
• WellPoint Buys CareMore In Reported $800M Deal
• The Perils Of One Wrong Word In A Contract
• Forest Labs Sales Reps Win Class Cert. In OT Suit
• Blue Cross Michigan Can't Dodge DOJ Antitrust Suit
• Fla. Hospital Not Immune From FCA Suit, Judge Rules
• Insurer Sues Ill. Over State Health Insurance Contracts
• Lundbeck Settles Antitrust Suit Over Infant Heart Drugs
• Fed. Circ. Won't Review Saint-Gobain Loss In Scanner Suit
• Patent Reform Bill Makes USPTO Too Powerful: House Reps.
• Fed. Circ. Affirms Invalidity Of J&J Stent Patents
• Merge Insurer Fights Coverage Of Entire 3M Fee Award
• 1-800 Contacts Uses IP Attacks To Quash Rivals: Suit
• Clarifying Obligation To Report Drug Patent Agreements
• Life Partners Could Face Expanded SEC Suit
• 7th Circ. Questions Ex-Abbott Workers' ERISA Suit Bid
• Blue Cross Tries To Dodge Price-Fixing Action In Mich.
• McKesson, Hearst Inflated Drug Prices, Mich. AG Says
• Blue Cross Underpaid Texas Claims By $11M: Suit
• Inventors Get 1st Dibs On Gov't-Funded IP: High Court
• Fed. Circ. Won't Revive $25M VA Contract Fight
• AstraZeneca Settles DOL Sex Bias Pay Dispute
• FDA Warns Impax Over Drug Testing At Calif. Plant
• Judge Trims MRI Class Action Against State Farm
• US Specialty Seeks To Nix Coverage In Dental Co. Row
• SEC Says Calif. Atty Stole Info On $2.8B Abbott Deal
• J&J Ordered To Pay $327M Over Risperdal Marketing
• $200M WellCare Health Settlement Isn't Fair: Investor
• Takeda Drops Suit Over Macleods' Actos ANDA
• Matrixx, Zicam Fail To Shut Down Cold Remedy MDL
• Federal Economic Crime Investigator Joins Kilpatrick
• Calif. Assembly OKs Health Insurance Rate Regulation
• A Lower-Cost Alternative To Litigation
• American Medical Settles Suits Over $2.9B Endo Buy
• Calif. County Seeks To Give US Drug Price-Fixing Docs
• Pfizer Sues Watson Over Viagra ANDA
• Ex-Hospital Exec Embezzled $1.7M, Feds Say
• GSK Denied Quick Win In Flonase Antitrust Cases
• SEC Widens Insider Trading Case Against FDA Chemist
• Pfizer Sues Impax Over Detrol ANDA
• Ex-CHM Workers Can Bring Collective OT Action: Judge
• Zicam Inventor Arrested Over Unapproved Bird Flu Drug
• Insurer On The Hook For Hospital Sex Abuse: Judge
• Squire Sanders Nabs Health Care Prosecutor
• Ropes & Gray Snags Former Assistant US Atty
• Orthovita Shareholders Sue Over $316M Stryker Deal
• Goodell DeVries Opens Pa. Office With Ex-Dechert Attys
• Ill. Hospital Prevails In 7th Circ. Antitrust Case
• Implications Of Fed. Circ.'s Therasense Opinion
• Industry Pressure Points May Shape Final ACO Rule
• 6th Circ. Mulls US Authority In Health Care Act Appeal
• Becton To Take Inequitable Conduct Fight To High Court
• 1st Circ. Revives Blackstone FCA Kickback Case
• Obama Administration Backs House Patent Reform Bill
• Endo Sales Reps Win Conditional Cert. For OT Suit
• Allergan, Hi-Tech Settle IP Case Over Generic Combigan
• Breach Claims Over Ventas-Nationwide Health Deal Nixed
• ReGen Sues FDA Over Menaflex Clearance Repeal
• Hydroxycut MDL Claims Fall Short, Judge Says
• Gentiva To Pay $12.5M Over Medicare Fraud Claims
• FTC Signs Off On Grifols-Talecris Deal Divestitures